Antigen associated with the neovasculature of tumour metastases
US9896503B2 · kind B2 · utility
2Cited by
7References
21Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 5, 2015 |
| Grant date | Feb 20, 2018 |
| Priority date | — |
| Expiry date | Apr 6, 2036 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2317/92
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention relates to a binding member that binds the Extra Domain-A (ED-A) isoform of fibronectin for the treatment of tumour metastases.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.